Navigation Links
Encorium Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity
Date:8/31/2009

ence across a wide variety of therapeutic areas such as infectious diseases, cardiovascular, vaccines, oncology, diabetes endocrinology/metabolism, gene therapy, immunology, neurology, gastroenterology, dermatology, hepatology, women's health and respiratory medicine. Encorium believes that its expertise in the design of complex clinical trials, its therapeutic experience and commitment to excellence, and its application of innovative technologies, offer its clients a means to more quickly and cost effectively move products through the clinical development process.

This press release contains forward-looking statements identified by words such as "estimate," "project," "expect," "intend," "believe," "anticipate" and similar expressions. Those statements involve risks and uncertainties, and actual results could differ materially from those discussed. Factors that could cause or contribute to such differences include, but are not limited to: (i) the risk that we may not have sufficient funds to operate our business; (ii)our success in attracting new business and retaining existing clients and projects; (iii) the size, duration and timing of clinical trials we are currently managing may change unexpectedly; (iv) the termination, delay or cancellation of clinical trials we are currently managing could cause revenues and cash-on-hand to decline unexpectedly; (v) the timing difference between our receipt of contract milestone or scheduled payments and our incurring costs to manage these trials; (vi) outsourcing trends in the pharmaceutical, biotechnology and medical device industries; (vii) the ability to maintain profit margins in a competitive marketplace; (viii) our ability to attract and retain qualified personnel; (ix) the sensitivity of our business to general economic conditions; (x) other economic, competitive, governmental and technological factors affecting our operations, markets, products, services and prices; (xi) announced awards received
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Encorium Group Amends LOI with Respect to the Sale of its U.S. Business;
2. Encorium Reports First Quarter 2009 Financial Results
3. Encorium Group Enters into Non-Binding Letters of Intent
4. Encorium Reports Fourth Quarter and Full Year 2008 Financial Results
5. Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing
6. Encorium Appoints Shahab Fatheazam to its Board of Directors
7. Scott & White Memorial Hospital Receives Level I Trauma Center Re-designation Again
8. Sundia Receives the Highest Growth Potential Award from Zhangjiang
9. The Eye Institute Receives 2009 Best of Rock Springs Award from U.S. Commerce Association
10. Provider of Diabetes Medical Supplies Receives 2009 Best of Boca Raton Award
11. Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... McLean, VA (PRWEB) May 20, 2013 ... (EDRA) Annual Conference will feature dozens of continuing ... approved by the American Institute of Architects Continuing ... System (LA CES), and the Interior Design Continuing ... May 29 – June 1, 2013 at the ...
(Date:5/20/2013)... Co-founder of Atlanta SEO company ... at the 5th International INVEST Domaining & Internet Marketing ... company representatives and independent individuals from around the world ... investments. , The 2013 conference will take place at ... May 20 to 21. A networking city tour day ...
(Date:5/20/2013)... May 20, 2013 The judge overseeing ... lawsuits has called specifically for female lawyers to be ... The Rottenstein Law Group LLP acknowledges the judge’s request, ... lawsuits by providing information on Mirena side effects ... Seibel called for the addition of some female lawyers ...
(Date:5/20/2013)... Branch at Galveston researchers have been awarded a five-year, ... Disorders and Stroke to apply the techniques of gene ... is, pain that arises from a malfunction in the ... reality for millions of Americans, manifesting itself in a ... might feel intense discomfort in response to a light ...
(Date:5/20/2013)... 20, 2013 Dorland Health, a ... the fourth annual Case In Point Platinum Awards, ... to ensuring the system is patient- and family-centric, ... innovative and creative work across the healthcare system ... safe transitions of care through effective care coordination ...
Breaking Medicine News(10 mins):Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:Pain, pain, go away 2Health News:Pain, pain, go away 3Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2
... ... Announced by ERISAclaim.com for Healthcare Providers to Appeal Claim Denials and Delays, to Comply with ... Plans And Healthcare Providers. , ... Hanover Park, IL (PRWEB) June 28, 2010 -- ERISAclaim.com announced the nation,s first new ...
... ... that provides a comprehensive view of California public policy and legislative issues. Available ... one site. , ... 28, 2010 -- The ‘LegisWeb Eye’ launches on July 1st, bringing a new legislative information ...
... lowered the obesity rate in students at highest risk for ... in sixth grade, an NIH-funded study has found. However, ... schools in the study,s primary outcomethe prevalence of overweight and ... schools by the end of the three-year study. The ...
... ... Tarot Professionals Ltd establishes Tarosophy® Tarot Houses worldwide ... being prepared to warn Tarot readers by highlighting certification scams, bad ... field. Tarot Professionals Ltd continues to introduce innovative Tarot courses – ...
... People with type 1 diabetes who have early and ... in the urine, are six times more likely to die ... of Pittsburgh Graduate School of Public Health. Their study, being ... Association, also found that when kidneys remained normal over time, ...
... , ... Henninger Media Services, the largest production/post-production company in the Mid-Atlantic region, acquires premiere ... Clients include National Geographic Films, Discovery Networks and various documentary filmmakers. ... (PRWEB) ...
Cached Medicine News:Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 2Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 3Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 4Health News:The 'LegisWeb Eye' Legislative Web Portal Launches on July 1st 2Health News:The 'LegisWeb Eye' Legislative Web Portal Launches on July 1st 3Health News:Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds 2Health News:Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds 3Health News:Tarosophy Deals A Fair Hand for All Tarot Seekers 2Health News:Tarosophy Deals A Fair Hand for All Tarot Seekers 3Health News:Tarosophy Deals A Fair Hand for All Tarot Seekers 4Health News:Henninger Media Services Now Offers Hollywood-Quality Blu-ray Products 2Health News:Henninger Media Services Now Offers Hollywood-Quality Blu-ray Products 3
(Date:5/20/2013)... 20, 2013   National Community Pharmacists Association ... RPh, MBA issued the following statement today regarding a ... Part D "preferred pharmacy" drug plans , which ... plan,s lowest advertised co-payments: (Logo:  http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ... and MedPAC , 16 U.S. Senators ...
(Date:5/20/2013)... , May 20, 2013  TRACE International today ... 2012 , finding that prosecutions against individuals and government ... last year. The GER 2012 is the ... international anti-bribery enforcement trends. "Although the number ... of bribery laws remained a priority," said ...
(Date:5/20/2013)... , May 20, 2013   Life Technologies ... that its Applied Biosystems™ 3500 Dx and 3500xL Dx ... for Protection against Health Risks in Mexico ... major extension of Life Technologies, capabilities to serve the ... with Sanger -based solutions.  ...
Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3
... both ethical and practical grounds, direct programming is ... pluripotent stem,cells.", WASHINGTON, Nov. 20 Two ... Cell unveil a proven way to,generate patient-matched human ... use of human embryos or human or animal ...
... of circulating cancer cells in 40,billion blood cells, ... WARREN, N.J., Nov. 20 Veridex, LLC ... (FDA) has granted an,expanded clearance for the CellSearch(TM) ... monitoring of metastatic colorectal cancer. CellSearch is currently,approved ...
Cached Medicine Technology:Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 2FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 3FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer 4
The ultimate combination of comfort, convenience and affordability, recommended for daily wear, also approved for extended wear (1-7 days)....
Acuvue2 is designed to be worn as a two-week daily wear lens (which means you take the lenses out each night). It can also be worn as a one-week extended wear lens (which means you can sleep in them)...
... water content spherical soft lens manufactured using ... molding technology, and designed for use in ... a daily wear or extended wear basis. ... transmission, while an increased mid-peripheral thickness allows ...
Hertel exophthalmometer...
Medicine Products: